Generic:

Sitagliptin 

Therapeutic Class:

DPP-IV Inh A-Diab Plain

Composition:

Each Glyzia tablet contains 50 or 100 mg of sitagliptin.

Description:

Glyzia tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl peptidase4 (DPP-4) enzyme

Indications:

Glyzia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

The recommended dose of Glyzia is 100 mg once daily. Glyzia can be taken with or without food.  

Presentation:
Glyzia Tab 50 mg and 100 mg is available in pack of 14’s.